Metastatic Renal Cell Carcinoma Recruiting Phase 1 Trials for Fludarabine (DB01073)

Also known as: Metastatic renal cell carcinoma (morphologic abnormality) / Metastatic renal cell carcinoma (disorder)

IndicationStatusPhase
DBCOND0030098 (Metastatic Renal Cell Carcinoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02926053TIL Therapy for Metastatic Renal Cell CarcinomaTreatment